April 28, 2026 Borealis Foods Announces $17.0 Million Refinancing Transaction with Oxus Capital to Repay Frontwell Facility and Support Operations
April 28, 2026 Vanda Pharmaceuticals announces the publication of “Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis” in NEJM Evidence
